Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai
Background: Treatment of multidrug-resistant tuberculosis (MDR-TB) in the Programmatic Management of Drug-resistant TB program involves a standard regimen with a 6-month intensive phase and an 18-month continuation phase. However, the local drug resistance patterns in high MDR regions such as Mumbai...
Main Authors: | Zarir F Udwadia, Jai Bharat Mullerpattan, Kushal D Shah, Camilla S Rodrigues |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Lung India |
Subjects: | |
Online Access: | http://www.lungindia.com/article.asp?issn=0970-2113;year=2016;volume=33;issue=3;spage=253;epage=256;aulast=Udwadia |
Similar Items
-
Treatment outcomes for multidrug-resistant tuberculosis in Eastern Taiwan
by: Chih-Bin Lin, et al.
Published: (2019-01-01) -
Treatment outcomes associated with multidrug-resistant tuberculosis
by: Nitin Gupta, et al.
Published: (2018-01-01) -
Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic
by: Zarir F. Udwadia, et al.
Published: (2019-01-01) -
Knowledge of tuberculosis management using directly observed treatment short course therapy among final year medical students in South Western Nigeria
by: Olarewaju Sunday Olakunle, et al.
Published: (2014-05-01) -
Noncompliance to directly observed treatment short course in Mulshi block, Pune district
by: Prasad D Pore, et al.
Published: (2020-01-01)